{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:11:36Z","timestamp":1782029496459,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11095-014-1508-y","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T19:57:13Z","timestamp":1410379033000},"page":"941-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Laronidase-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Promising Formulation for a More Effective Treatment of Mucopolysaccharidosis Type I"],"prefix":"10.1007","volume":"32","author":[{"given":"Fabiana Quoos","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Duarte","family":"Adorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Andr\u00e9","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita Giacomet","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Cl\u00e1udia","family":"Dilda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy Carlos Ruver","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Stanis\u00e7uaski","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Matte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Raffin","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"issue":"1","key":"1508_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.peptides.2009.10.002","volume":"31","author":"ML Tan","year":"2010","unstructured":"Tan ML, Choong PF, Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides. 2010;31(1):184\u201393.","journal-title":"Peptides"},{"issue":"1\u20132","key":"1508_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(99)00247-3","volume":"65","author":"GP Carino","year":"2000","unstructured":"Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J Control Release. 2000;65(1\u20132):261\u20139.","journal-title":"J Control Release"},{"issue":"Suppl 2","key":"1508_CR3","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0928-0987(00)00166-4","volume":"11","author":"VP Torchilin","year":"2000","unstructured":"Torchilin VP. Drug targeting. Eur J Pharm Sci. 2000;11 Suppl 2:S81\u201391.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1508_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.copbio.2007.01.006","volume":"18","author":"SD Caruthers","year":"2007","unstructured":"Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotechnol. 2007;18(1):26\u201330.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"1508_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","volume":"47","author":"J Kreuter","year":"2001","unstructured":"Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Ver. 2001;47(1):65\u201381.","journal-title":"Adv Drug Deliv Ver"},{"key":"1508_CR6","first-page":"37","volume":"5","author":"M Marco Di","year":"2010","unstructured":"Di Marco M, Shamsuddin S, Razak KA, et al. Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation. Int J Nanomedicine. 2010;5:37\u201349.","journal-title":"Int J Nanomedicine"},{"issue":"50","key":"1508_CR7","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1002\/anie.200801711","volume":"47","author":"P Jonkheijn","year":"2008","unstructured":"Jonkheijn P, Weinrich D, Schr\u00f6der H, Niemeyer CM, Waldmann H. Chemical strategies for generating protein biochips. Angew Chem Int Ed Engl. 2008;47(50):9618\u201347.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"1508_CR8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cbpa.2010.10.001","volume":"14","author":"S Rana","year":"2010","unstructured":"Rana S, Yeh YC, Rotello VM. Engineering the nanoparticle\u2013protein interface: applications and possibilities. Curr Opin Chem Biol. 2010;14(6):828\u201334.","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"1508_CR9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1166\/jbn.2009.1004","volume":"5","author":"E Jager","year":"2009","unstructured":"Jager E, Venturini CG, Poletto FS, et al. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol. 2009;5(1):130\u201340.","journal-title":"J Biomed Nanotechnol"},{"key":"1508_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.colsurfa.2010.12.011","volume":"375","author":"CG Venturini","year":"2011","unstructured":"Venturini CG, J\u00e4ger E, Oliveira CP, et al. Formulation of lipid core nanocapsules. Colloids and Surf A: Physicochem Eng Aspects. 2011;375:200\u20138.","journal-title":"Colloids and Surf A: Physicochem Eng Aspects"},{"key":"1508_CR11","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1039\/c2sm25754h","volume":"8","author":"DS Jornada","year":"2012","unstructured":"Jornada DS, Fiel LA, Bueno K, et al. Lipid-core nanocapsules: mechanism of self-assembly, control of size and loading capacity. Soft Matter. 2012;8:6646\u201355.","journal-title":"Soft Matter"},{"key":"1508_CR12","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1039\/c1sm05508a","volume":"7","author":"LA Fiel","year":"2011","unstructured":"Fiel LA, Rebelo LM, Santiago TM, et al. Diverse deformation properties of polymeric nanocapsules and lipid-core nanocapsules. Soft Matter. 2011;7:7240\u20137.","journal-title":"Soft Matter"},{"issue":"6","key":"1508_CR13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuint.2010.07.012","volume":"57","author":"A Bernardi","year":"2010","unstructured":"Bernardi A, Frozza RL, Horn AP, et al. Protective effects of indomethacin-loaded nanocapsules against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of neuroinflammation. Neurochem Int. 2010;57(6):629\u201336.","journal-title":"Neurochem Int"},{"issue":"4","key":"1508_CR14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2009.00244.x","volume":"158","author":"A Bernardi","year":"2009","unstructured":"Bernardi A, Zilberstein AC, Jager E, et al. Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats. Br J Pharmacol. 2009;158(4):1104\u201311.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1508_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2009.02.018","volume":"281","author":"A Bernardi","year":"2009","unstructured":"Bernardi A, Braganhol E, Jager E, et al. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Lett. 2009;281(1):53\u201363.","journal-title":"Cancer Lett"},{"key":"1508_CR16","doi-asserted-by":"crossref","unstructured":"Ourique AF, Azoubel S, Ferreira CV, et al. Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: development and in vitro antitumor activity on human myeloid leukaemia cells. J Biomed Nanotechnol. 2010;6(3):214\u201323.","DOI":"10.1166\/jbn.2010.1120"},{"issue":"6","key":"1508_CR17","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1166\/jbn.2010.1161","volume":"6","author":"RL Frozza","year":"2010","unstructured":"Frozza RL, Bernardi A, Paese K, et al. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J Biomed Nanotechnol. 2010;6(6):3694\u2013703.","journal-title":"J Biomed Nanotechnol"},{"issue":"1\u20132","key":"1508_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2012.01.051","volume":"426","author":"EA Bender","year":"2012","unstructured":"Bender EA, Adorne MD, Colome LM, et al. Hemocompatibility of poly(epsilon-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm. 2012;426(1\u20132):271\u20139.","journal-title":"Int J Pharm"},{"key":"1508_CR19","volume-title":"New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(-)-functionalized nanocapsules","author":"EA Bender","year":"2014","unstructured":"Bender EA, Cavalcante MF, Adorne MD, et al. New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(-)-functionalized nanocapsules. Res: Pharm; 2014. doi: 10.1007\/s11095-014-1392-5 ."},{"key":"1508_CR20","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1039\/c1sm05509g","volume":"7","author":"F Reynaud","year":"2011","unstructured":"Reynaud F, Tsapis N, Deyme M, et al. Spray-dried chitosan-metal microparticles for ciprofloxacin adsorption: Kinetic and equilibrium studies. Soft Matter. 2011;7:7304\u201312.","journal-title":"Soft Matter"},{"key":"1508_CR21","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J. The Mucopolysaccharidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001. p. 3421\u201352."},{"key":"1508_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/phe.10.5","volume":"4","author":"R Giugliani","year":"2010","unstructured":"Giugliani R, Ferderhen A, Carvalho CG, Artigalas O. Enzyme replacement therapy for Mucopolysaccharidosis type I: Laronidase. Pediatr Health. 2010;4:133\u201345.","journal-title":"Pediatr Health"},{"issue":"3","key":"1508_CR23","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1590\/S1413-81232010000900019","volume":"15","author":"MV Souza","year":"2010","unstructured":"Souza MV, Krug BC, Picon P, Schwartz IVD. Medicamentos de alto custo para doen\u00e7as raras no Brasil: o exemplo das doen\u00e7as lisoss\u00f4micas. Ci\u00eancia e Sa\u00fade Coletiva. 2010;15(3):3443\u2013554.","journal-title":"Ci\u00eancia e Sa\u00fade Coletiva"},{"issue":"3","key":"1508_CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S0104-42302010000300009","volume":"56","author":"R Giugliani","year":"2010","unstructured":"Giugliani R, Federhen A, Mu\u00f1oz Rojas MV, et al. Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts. Rev Assoc Med Bras. 2010;56(3):271\u20137.","journal-title":"Rev Assoc Med Bras"},{"issue":"2","key":"1508_CR25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0039-9140(99)00129-0","volume":"50","author":"O Mengual","year":"1999","unstructured":"Mengual O, Meunier G, Cayre I, Puech K, Snabre P. TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis. Talanta. 1999;50(2):445\u201356.","journal-title":"Talanta"},{"key":"1508_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1508_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0009-8981(79)90121-9","volume":"92","author":"JJ Hopwood","year":"1979","unstructured":"Hopwood JJ, Muller V, Smithson A, Baggett N. A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes. Clin Chim Acta. 1979;92(2):257\u201365.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1508_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265\u201375.","journal-title":"J Biol Chem"},{"key":"1508_CR29","unstructured":"The European Commission, 2011\/696\/EU, Official Journal of the European Union, ISSN 1977-0677. 2011;54:L275."},{"issue":"3","key":"1508_CR30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000323273","volume":"24","author":"NM Siqueira","year":"2011","unstructured":"Siqueira NM, Contri RV, Paese K, et al. Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules. Skin Pharmacol Physiol. 2011;24(3):166\u201374.","journal-title":"Skin Pharmacol Physiol"},{"key":"1508_CR31","first-page":"202","volume-title":"Princ\u00edpios de bioqu\u00edmica de Lehninger","author":"DL Nelson","year":"2006","unstructured":"Nelson DL, Cox MM. Enzimas. In: Nelson DL, Cox MM, editors. Princ\u00edpios de bioqu\u00edmica de Lehninger. S\u00e3o Paulo: Sarvier; 2006. p. 202\u201312."},{"issue":"1","key":"1508_CR32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.colsurfb.2009.03.007","volume":"72","author":"C Celia","year":"2009","unstructured":"Celia C, Trapasso E, Cosco D, Paolino D, Fresta M. Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B: Biointerfaces. 2009;72(1):155\u201360.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"3","key":"1508_CR33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/anie.200503084","volume":"45","author":"BI Ipe","year":"2006","unstructured":"Ipe BI, Niemeyer CM. Nanohybrids composed of quantum dots and cytochrome P450 as photocatalysts. Angew Chem Int Ed Engl. 2006;45(3):504\u20137.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"1508_CR34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/bc800294a","volume":"20","author":"AJ Graaf de","year":"2009","unstructured":"de Graaf AJ, Kooijman M, Hennink WE, Mastrobattista E. Nonnatural amino acids for site-specific protein conjugation. Bioconjug Chem. 2009;20(7):1281\u201395.","journal-title":"Bioconjug Chem"},{"issue":"3","key":"1508_CR35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/ja037470o","volume":"126","author":"R Hong","year":"2004","unstructured":"Hong R, Fischer NO, Verma A, et al. Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. J Am Chem Soc. 2004;126(3):739\u201343.","journal-title":"J Am Chem Soc"},{"issue":"15","key":"1508_CR36","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1021\/ja042717i","volume":"127","author":"JM Abad","year":"2005","unstructured":"Abad JM, Mertens SF, Pita M, Fernandez VM, Schiffrin DJ. Functionalization of thioctic acid-capped gold nanoparticles for specific immobilization of histidine-tagged proteins. J Am Chem Soc. 2005;127(15):5689\u201394.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"1508_CR37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2004.12.006","volume":"85","author":"BP Rempel","year":"2005","unstructured":"Rempel BP, Clarke LA, Withers SG. A homology model for human alpha-l-iduronidase: insights into human disease. Mol Genet Metab. 2005;85(1):28\u201337.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1508_CR38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1163\/156856207779996931","volume":"18","author":"M Goldberg","year":"2007","unstructured":"Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 2007;18(3):241\u201368.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"1","key":"1508_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2008.10.009","volume":"96","author":"R Giugliani","year":"2009","unstructured":"Giugliani R, Rojas VM, Martins AM, et al. A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I. Mol Genet Metab. 2009;96(1):13\u20139.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1508_CR40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/jpet.107.133298","volume":"325","author":"C Garnacho","year":"2008","unstructured":"Garnacho C, Dhami R, Simone E, et al. Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther. 2008;325(2):400\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"1508_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2010.10.031","volume":"149","author":"J Hsu","year":"2011","unstructured":"Hsu J, Serrano D, Bhowmick T, et al. Enhanced endothelial delivery and biochemical effects of \u03b1-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release. 2011;149:323\u201331.","journal-title":"J Control Release"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-014-1508-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1508-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T20:48:03Z","timestamp":1650142083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-014-1508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1508"],"URL":"https:\/\/doi.org\/10.1007\/s11095-014-1508-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,11]]}}}